Table 3.

Secondary Outcomes and Mediating Variables

Domain	Measure	Timepointa
Threat Beliefs	Risk Behavior Diagnosis Scale[133, 134] perceived susceptibility and severity of HBOC subscales	T1, T2, T3, T4
Efficacy Beliefs	Risk Behavior Diagnosis Scale[133, 134] self-efficacy and response efficacy regarding genetic counseling subscales	T1, T2, T3, T4
Fear	Fear of HBOC risk (self, family): Affect in Risk Scale[135–137]	T1, T2, T3
Defensive Avoidance	Defensive Avoidance[35, 138]	T1, T2, T3
Distress, Stress and Worry	Cancer Worry Scale; [139, 140] Psychological distress: anxiety and depression subscales of the Brief Symptom Inventory;[141–143] Short Perceived Stress Scale[144, 145]	T1, T2, T3, T4
Decisional Regret and Satisfaction about genetic counseling and testing decisions	SURE Scale[146, 147]; Decision Satisfaction Scale[148, 149] and original contributions	T1, T2, T3, T4
Genomics and HBOC Knowledge	Items from the National Center for Human Genome Research Knowledge Scale and additional items specific to breast and ovarian cancer survivors[150, 151]; Original contributions assess whether participants heard about or were referred for CGRA and HBOC genetic testing (e.g., BRCA1/2) prior to being contacted for this study	T1, T2
Genetic Self Efficacy	Items assess confidence in their ability to understand genetic information and how it applies to personal health[152–154]	T1, T2
Belief that the GINA law would adequately protect against genetic based discrimination	Genetic Information Non-Discrimination Act (GINA) Law Confidence Scale[155]	T1, T2
Facilitators and Barriers Regarding CGRA	Facilitators and Barriers to genetic counseling and testing at the individual, interpersonal, structural and system-level are assessed[23, 101, 105, 108]	T1, T2, T3, T4

^aT1 = baseline; T2 = 1 month after baseline for UC or 1 month following TP or TCN; T3 = 6 months after baseline for UC or 6 months following TP or TCN; T4 = 12 months after baseline for UC or 12 months from TP or TCN